Juniper Pharma (JNP) Misses Q1 EPS by 9c

Juniper Pharma (NASDAQ: JNP) reported Q1 EPS of ($0.06), $0.09 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $8.3 million versus the consensus estimate of $7.8 million.

Adjusted EBITDA was $0.4 million in the first quarter of 2015 compared with $0.5 million in the first quarter of 2014.

For earnings history and earnings-related data on Juniper Pharma (JNP) click here.

You May Also Be Interested In

• TJX Cos. (TJX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance
• Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance
• Weibo (WB) Tops Q2 EPS by 2c